Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease

NCT01284387 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

BIOLOGICAL: ACC-001 (vanutide cridificar)

Sponsor

JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Collaborators

[object Object]